Wed, 23rd Jun 2021 11:58
LONDON, June 23 (Reuters) - GSK Chief Executive Emma
Walmsley plans to stay on as leader of the company after it
splits from its consumer healthcare business next year, she said
on Wednesday.
"My focus is resolutely on leading us through this
transformation, through a successful separation, and with
momentum beyond that," Walmsley told a news briefing when asked
about her future.
(Reporting by Pushkala Aripaka and Ludwig Burger
Writing by Keith Weir
Editing by Mark Potter)
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related...
(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application ...
(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jempe...
(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea...
Glaxosmithkline (GSK)